1-3 of 3
Hyae Young Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy

Young Joo Lee, Kyong-Ah Yoon, Ji-Youn Han, Heung Tae Kim, Tak Yun, Geon Kook Lee, Hyae Young Kim, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5179–5187.
https://doi.org/10.1158/1078-0432.CCR-11-0400
Published: 31 July 2011
View article titled, Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy
Open the PDF for Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy in another window
Includes: Supplementary data
Journal Articles

Gefitinib as a First-Line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung in Never-Smokers

Dae Ho Lee, Ji-Youn Han, Hong Gi Lee, Jae Jin Lee, Eun Kyoung Lee, Hyae Young Kim, Hark Kyun Kim, Eun Kyung Hong, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (8): 3032–3037.
https://doi.org/10.1158/1078-0432.CCR-04-2149
Published: 18 April 2005
View article titled, Gefitinib as a First-Line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung in Never-Smokers
Open the PDF for Gefitinib as a First-Line Therapy of Advanced or Metastatic Adenocarcinoma of the Lung in Never-Smokers in another window
Journal Articles

A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer

Ji-Youn Han, Dae Ho Lee, Hyae Young Kim, Eun-A Kim, Jae Jin Lee, So Young Ju, Eun Hee Shin, Jin Soo Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5909–5914.
Published: 15 December 2003
View article titled, A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer
Open the PDF for A Phase II Study of Weekly Irinotecan and Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer in another window